Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
These are the same formulas trusted by elite athletes worldwide
Insulin resistance: Paradoxically, while acute IGF-1 LR3 administration enhances insulin sensitivity, some research suggests chronic administration may produce compensatory insulin resistance over extended periods (12+ weeks)
At Golden Health and Beauty Center, patients receive guidance on what to expect during each phase of recovery
A4: Normally, we would recommend having these drips done at least once a month or two as a maintenance visit Clinic Information [Clinic Name] Omotesando General Medical Clinic [Location] Tokyo, Japan [Nearest Station/ Nearest Tourist Destination] 5 minutes walk from Tokyo Metro Omotesando Station [Clinic Opening Time] Friday - Wednesday (10:00AM - 7:00PM)
Papi A, Contoli M, Gasparini P, Bristot L, Edwards MR, Chicca M, et al